Embed Size (px)
DESCRIPTION
Glycaemic control after 16 weeks of alogliptin/pioglitazone, alogliptin or placebo treatment. 1.0. 0.5. 0.0. Change in A1c (%). -0.5. -1.0. -1.5. placebo. ALO. ALO/PIO. Van Raalte et al., Eur. J Endocrinology 2014. - PowerPoint PPT Presentation
Citation preview
Glycaemic control after 16 weeks of alogliptin/pioglitazone, alogliptin or placebo treatment
placebo ALO/PIOALO
0.0
-1.5
-0.5
-1.0
0.5
1.0
Chan
ge in
A1c
(%)
Van Raalte et al., Eur. J Endocrinology 2014
